Akap5 links synaptic dysfunction to neuroinflammatory signaling in a mouse model of infantile neuronal ceroid lipofuscinosis. [PDF]
Koster KP +8 more
europepmc +1 more source
Intraventricular Cerliponase Alfa Treatment in a Patient with Advanced Neuronal Ceroid Lipofuscinosis Type 2. [PDF]
Nakashima S +9 more
europepmc +1 more source
Recognizing Lipofuscinosis as a Guide in Antiepileptic Treatment: Clinical Description of the First Mexican Case With Neuronal Ceroid Lipofuscinosis Type 7 (NCL7). [PDF]
Kimball TN +4 more
europepmc +1 more source
TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2. [PDF]
Vafaei N +10 more
europepmc +1 more source
The value of a comprehensive natural history in late infantile CLN5 disease [PDF]
Mole, SE
core
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa. [PDF]
Guelbert N +34 more
europepmc +1 more source
VaProS: a database-integration approach for protein/genome information retrieval [PDF]
core +1 more source
Corrigendum to "Classic and atypical late infantile neuronal ceroid lipofuscinosis in Latin America: Clinical and genetic aspects, and treatment outcome with cerliponase alfa." [Molecular Genetics and Metabolism ReportsVolume 38 (2024) 101060]. [PDF]
Guelbert N +34 more
europepmc +1 more source
A Rare Case of Neuronal Ceroid Lipofuscinosis-Type 1 (NCL-1) with Vitamin D-Dependent Rickets-Type 1 (VDDR-1), Complex 1 Mitochondrial Deficiency, and Mixed Variant-Checkerboard and Phylloid Type of Pigmentary Mosaicism. [PDF]
Gowda VK +9 more
europepmc +1 more source

